Press Releases-EdiGene

Press Releases

23
2021-11

EdiGene Enters Research Collaboration to Develop Gene-editing Therapies for Inherited Retinal Degeneration with Peking Union Medical College Hospital

LEARN MORE
09
2021-11

EdiGene Enters Research Collaboration with the University of Wisconsin-Madison on in Vivo RNA Editing Therapies

LEARN MORE
04
2021-11

EdiGene to Present Latest Research on a Novel Surface Marker and Migration of Hematopoietic Stem Cell (HSC) that could Enhance HSC Gene Therapy and HSC Transplantation at the 63rd American Society of Hematology (ASH) Annual Meeting and Exposition

LEARN MORE
02
2021-11

EdiGene Secures New Lab and Office Space for Its Growing U.S. R&D Center to Advance Gene-editing Based Therapies

LEARN MORE
08
2021-09

EdiGene Announces Clinical Sites Activation and First Patient Enrolled in Multicenter Phase I Clinical Trial of its Investigational Gene-editing Hematopoietic Stem Cell Therapy ET-01 for Patients with Transfusion Dependent β-thalassemia

LEARN MORE
21
2021-04

EdiGene Raises Approximately USD 62 Million in Series B Plus Financing and Expands Operation Locations to Advance and Scale Up Clinical Translation of Gene Editing Technologies

LEARN MORE
18
2021-01

EdiGene Announces Approval of its IND Application for its CRISPR/Cas 9 Gene-editing Hematopoietic Stem Cell Therapy ET-01 in β-thalassemia by China National Medical Products Administration

LEARN MORE
14
2020-12

EdiGene Expands Management Team by Appointment of Head of US Subsidiary Dr. Bo Zhang and Head of Business Development Dr. Kehua Fan

LEARN MORE
27
2020-10

EdiGene Announces IND Application for its CRISPR/Cas 9 Gene-editing Hematopoietic Stem Cell Therapy ET-01 in β-thalassemia Accepted for Review by China National Medical Products Administration

LEARN MORE
13
2020-10

EdiGene Raises Approximately USD 67 Million in Series B Financing to Advance Gene Editing Based Programs into Clinical Stage

LEARN MORE

Edit Code of Life,Creating Transformative Solutions for Serious Human Diseases

Press Releases